Enrolling by invitationNCT04734626

CrCest Study in Primary Mitochondrial Disease

Studying Mitochondrial disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital of Philadelphia
Principal Investigator
Zarazuela Zolkipli Cunningham, MBChB MRCP
Children's Hospital of Phiadelphia
Intervention
Creatine Chemical Exchange Saturation Transfer (CrCEST) Imaging Sequence(diagnostic_test)
Enrollment
230 target
Eligibility
7-75 years · All sexes
Timeline
2021 – 2028

Study locations (1)

Collaborators

National Institutes of Health (NIH) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04734626 on ClinicalTrials.gov

Other trials for Mitochondrial disease

Additional recruiting or active studies for the same condition.

See all trials for Mitochondrial disease →

← Back to all trials